AI Speed-to-Lead Follow-Up Services for Medical Weight Loss Clinic (GLP-1/Semaglutide)s

Patient no-shows are draining your consult calendar — 23.5% of appointments never happen

For a GLP-1/Semaglutide clinic, every missed consult is a lost titration visit, a delayed lab draw, and a month of revenue gone. Patient no-show rates in U.S. healthcare range from 5.5% to 50%, with a global average of 23.5% — and the industry absorbs an estimated $150 billion annually in no-show costs. Weight loss clinics feel it twice: the patient who no-shows their initial consult often never re-engages, and persistence with GLP-1 therapies in obesity-focused settings already falls below 10% by 24 months. A lead that waits hours for a callback — while shopping three other Semaglutide providers — is gone before your front desk ever dials.

Delayed response kills conversion in a market growing 17.5% annually

The GLP-1 receptor agonist market is projected to grow from $62.86 billion in 2025 to $315.33 billion by 2035 — a 17.5% CAGR — with North America holding 76% of global share. That means more high-intent patients inquiring every day, and more competitors racing to answer them. Contacting a lead within five minutes makes contact roughly 100x more likely than at thirty minutes, and about of buyers choose whoever responds first. When a prospective patient asks about Semaglutide pricing, insurance navigation, or GI tolerability and hears nothing for hours, they book with the clinic that answered in minutes.

GLP-1 persistence falls below 10% in obesity care — your dormant list is full of lapsed patients

Persistence with GLP-1 therapies tells a hard story: 75–80% at 12 months in reimbursed type 2 diabetes cohorts, but below 10% in obesity-focused or high out-of-pocket-cost settings — and below 15% by 24 months in several cohorts. Treatment interruptions driven by cost, insurance navigation friction, and gastrointestinal tolerability issues leave weight loss clinics sitting on thousands of opted-in former patients who paused therapy and were never contacted again. That dormant CRM list is your cheapest source of reactivated consults — if someone actually reaches out.

Increase lead contact rates by up to 100x

Every lead your clinic receives — fresh or reactivated — gets AI voice, SMS, and email follow-up inside a five-minute window, 24/7. When a prospective patient submits an inquiry about Semaglutide at 9pm, the AI responds in minutes, qualifies intent, and books the consult or hands your team a warm contact — no more losing evening and weekend inquiries to whoever answers first.

Contacting a lead within five minutes makes contact roughly 100x more likely than at thirty minutes, and about of buyers choose whoever responds first.

Re-engage 8–15% of dormant opted-in CRM lists

Upload or connect your opted-in dormant patient list and a multi-channel AI sequence — SMS first, voice follow-up, email backup — re-engages and qualifies lapsed GLP-1 patients, then pushes them back into your CRM. Reactivation campaigns run 30–90 days and are priced per qualified reactivation at 60–80% below new-lead cost, turning your paused-therapy database into a predictable consult pipeline.

Typically 8–15% of a dormant, opted-in database re-engages through the multi-channel AI sequence.

Fully compliant with FCC one-to-one consent and DNC rules

Every lead arrives with a full consent record — disclosure text, timestamp, IP address, and the named contacting party — and lists are DNC-scrubbed before any outbound contact. Opt-outs are honored immediately and permanently across SMS, voice, and email, with FCC one-to-one consent direction built in from day one. For a medical practice, that means compliant outreach without guesswork.

Every lead carries a consent record with disclosure text, timestamp, IP address, and named contacting party; lists are DNC-scrubbed before contact and opt-outs honored permanently across all channels.

Tell us your niche and goal

Specify Medical Weight Loss Clinic (GLP-1/Semaglutide) as your niche and whether you want exclusive leads, dead list reactivation, or both.

We source and follow up with AI

We deliver qualified, consent-recorded leads or run AI sequences on your opted-in list, then follow up with voice, SMS and email within five minutes.

Leads land in your CRM with consent trail

Qualified leads appear in your CRM via webhook, Zapier or native integration, each with full consent documentation attached.